IMPACT OF PSYCHOLOGICAL TREATMENT (INFORMATIONAL CARE AND SUPPORTIVE COUNSELLING) ON PATIENT OUTCOMES IN PSORIASIS: A RANDOMIZED CONTROLLED TRIAL
Main Article Content
Keywords
Psoriasis, Informational care, Supportive Counselling, Quality of Life, Treatment Adherence, PASI, DLQI
Abstract
Psoriasis is a chronic, immune-mediated dermatologic condition, globally affecting 0.6% to 4.8%. Up to 40% of psychiatric patients are non-compliant due to stigma and distress.
Objective: This study was carried out to determine the effect of informational care and supportive counselling on treatment outcomes in psoriatic patients in relation to disease severity, quality of life, and drug adherence.
Methods: A parallel-group randomized controlled trial was conducted with a 1:1 allocation ratio. A total of 104 psoriasis patients aged 18–65 was randomly selected from Sohail Trust Hospital and Medicare Hospital using a computer-generated random number table. Allocation concealment was maintained using sealed opaque envelopes. The intervention group received structured educational sessions and personalized supportive counselling. The control group received standard dermatologic care. PASI, DLQI, and a medication adherence questionnaire were used to assess outcomes. Statistical analysis included independent and paired t-tests and repeated measures ANOVA.
Results: Significant improvements were observed in the intervention group: PASI scores decreased from 18.31 to 9.6, DLQI from 12.48 to 6.90, and medication adherence scores from 5.85 to 4.60. No adverse events were reported.
Conclusion: Informational care and supportive counselling significantly improved clinical outcomes, quality of life, and treatment adherence in psoriasis patients. These findings support incorporating psychosocial support into routine dermatologic management.
References
Risk factors associated with burden of disease of psoriasis from 1990 to 2019: Epidemiological analysis. JMIR Dermatology, 7, e48749. https://doi.org/10.2196/48749
2. Doger, E., & Erdem, T. (2007). Nature of cell kinetics in psoriatic epidermis. Journal of Cutaneous Pathology, 34(1), 52–57. https://doi.org/10.1111/j.1600-0560.2006.00719.x
3. Richards, H. L., Fortune, D. G., & Griffiths, C. E. M. (2006). Psychological distress and adherence in patients with psoriasis. Journal of the European Academy of Dermatology and Venereology, 20(s2), 33–41. https://doi.org/10.1111/j.1468-3083.2006.01771.x
4. Homayoon, D., Hiebl-Ragger, M., Zenker, M., Weger, W., Unterrainer, H. F., & Aberer, E. (2020). Relationship between skin shame, psychological distress, and quality of life in patients with psoriasis: A pilot study. Acta Dermato-Venereologica, 100(14), 5813. https://doi.org/10.2340/00015555-3563
5. Bakar, R. S., Jaapar, S. Z. S., Azmi, A. F., & Aun, Y. C. (2021). Depression and anxiety among patients with psoriasis: A correlation with quality of life and associated factors. Journal of Taibah University Medical Sciences, 16(4), 491–496. https://doi.org/10.1016/j.jtumed.2021.02.008
6. Kumar, S., Kumar, S., & Yadav, S. (2023). Psychiatric morbidities and their impact on quality of life in patients with psoriasis. Journal of Clinical and Diagnostic Research, 17(3), WC01–WC04. https://doi.org/10.7860/JCDR/2023/51734.17080PubMed
7. Li, X., Liu, L., Zhang, Y., & Li, L. (2020). Efficacy of psychological intervention for patients with psoriasis vulgaris: A prospective study. Journal of International Medical Research, 48(10), 0300060520961674. https://doi.org/10.1177/0300060520961674
8. Arabi, A., Hasani, J., Akbari, M., Hatami, M., & Sherbafchi Zadeh, M. R. (2023). Comparing the effectiveness of cognitive-behavioral therapy and compassion-focused therapy on psychological distress and quality of life of psoriasis patients. International Journal of Body, Mind and Culture, 10(4), 339–347. https://doi.org/10.22122/ijbmc.v10i4.339.
9. Kumar, S., Kumar, S., & Yadav, S. (2023). Psychiatric morbidities and their impact on quality of life in patients with psoriasis. Journal of Clinical and Diagnostic Research, 17(3), WC01–WC04. https://doi.org/10.7860/JCDR/2023/51734.17080
10. Shaukat, A., Rashid, S., & Sadiq, M. (2023). Coping strategies, emotion regulation and quality of life among psoriasis patients. The International Journal of Psychiatry in Medicine, 58(5), 382–394. https://doi.org/10.1177/00912174231170204
11. Chronic psychological stress exacerbates psoriasis-like skin inflammation via overactivation of β2-adrenoceptor and nuclear factor kappa B pathways. Scandinavian Journal of Immunology, 2023. https://doi.org/10.1111/sji.13146
12. Proinflammatory cytokines and neuropeptides in psoriasis, depression, and anxiety. Scandinavian Physiological Society, 2025. https://doi.org/10.1111/sps.13245
13. Sondermann, W., Künzli, A., & Rüegg, S. (2021). Psychological burden of psoriatic patients in a German university hospital dermatology department. The Journal of Dermatology, 48(6), 859–866. https://doi.org/10.1111/1346-8138.15721
14. Daglioglu, E. B. Y., Aksoy, M., & Cadirci, D. (2020). Effects of disease severity on quality of life in patients with psoriasis. Dermatologic Therapy, 33(6), e14422. https://doi.org/10.1111/dth.14422
15. Nagarajan, P., & Thappa, D. M. (2018). Effect of an educational and psychological intervention on knowledge and quality of life among patients with psoriasis. Indian Dermatology Online Journal, 9(1), 27–32. https://doi.org/10.4103/idoj.IDOJ_111_17
16. A systematic review of cognitive and behavioral treatments for individuals with psoriasis. Journal of Dermatological Treatment, 31(6), 631–638. https://doi.org/10.1080/09546634.2019.1690625
17. Xiao, Y., Zhang, X., Luo, D., Kuang, Y., Zhu, W., Chen, X., & Shen, M. (2019).
The efficacy of psychological interventions on psoriasis treatment: A systematic review and meta-analysis of randomized controlled trials. Psychological Research and Behavioral Management, 12, 97–106. https://doi.org/10.2147/PRBM.S195181
18. Tengattini, V., Foschi, L., Rucci, P., Iommi, M., & Bardazzi, F. (2019). Effectiveness of psychological intervention in psoriatic patients relative to standard care. European Journal of Dermatology, 29(2), 231–233. https://doi.org/10.1684/ejd.2019.3515

